# Dow hits record highs as Tesla and Lilly crush it — rotate into old-economy winners

_AI-generated trading idea · LONG · DIA, LLY, TSLA_

> Canonical page: https://commonquant.ai/research/for-you/dow-hits-record-highs-as-tesla-and-lilly-crush-it-rotate-int--43884134-547b-4cd6-886f-5b5e75b17561

Tesla just crushed its delivery numbers, joining other non-tech companies like Eli Lilly in pushing the Dow to record highs. Meanwhile, AI-related tech stocks like Micron are getting crushed by supply fears—this is a clear signal that old-economy stocks are taking the market's spotlight.

## Idea

Tesla's massive delivery beat is giving the stock a huge boost, proving that consumer-facing companies can still grow despite macro uncertainty. This aligns with the broader market divergence where the Dow is hitting record highs thanks to companies like Eli Lilly, while the tech-heavy Nasdaq struggles as memory-chip makers face a supply glut. The combination of strong consumer demand (Tesla) and sector leadership shifting away from overheated AI chips signals a healthy broadening of the stock market rally.

## Advanced Analysis

### Verdict: skip the trade — the rotation thesis is real but the strategy and TSLA fundamentals don't support it

The rotation narrative is real — the CNBC coverage confirms the Dow hitting records while the Nasdaq slipped, and Eli Lilly's 44.7% revenue growth with a 77.8% return on equity is the kind of fundamental backing a thesis needs. But this strategy trades TSLA, not the rotation theme, and Tesla's own numbers undercut the bull case: revenue contracted 2.9%, diluted EPS fell 47.1%, and the gross margin sits in just the 21st percentile of its sector. The backtest seals the verdict — while the 60-month window showed a 6.9% return, the most recent 24-month window lost 7.5% with a 33% win rate, and every parameter variant failed the final 12-month holdout, producing a no-recommendation result. No robust setup was established, and with TSLA trading at $380.84 against a 50-day SMA of $400.59 and an ADX of 14.4 versus the required 25, the entry conditions are not close to triggering today. Wait for a fundamental catalyst that actually reverses Tesla's margin and earnings trajectory before deploying capital.

\*\*Conviction breakdown:\*\*
\- \*\*Thesis support (58):\*\* The old-economy rotation is genuine and well-documented, but Tesla's contribution to the thesis is the weakest link.
\- \*\*Trade readiness (30):\*\* TSLA is below its 50-day SMA and ADX is far below the entry threshold; the setup is not near firing.
\- \*\*Risk quality (45):\*\* A 12% stop on a stock with 42.9% annualized volatility and a 53.8% historical drawdown leaves meaningful gap risk unaddressed.
\- \*\*Backtest evidence (35):\*\* The holdout returned -7.6% with a 26.4% win rate, and no parameter variant was recommended.
\- \*\*Fundamentals trend (50):\*\* Eli Lilly's numbers are elite, but TSLA's revenue contraction and margin percentile drag the basket's fundamental quality down.

#### Conviction score breakdown

Composite score computed by the server from the applicable evidence-tier dimensions.

| Measure | Value |
| --- | ---: |
| Thesis support | 58/100 |
| Trade readiness | 30/100 |
| Risk quality | 45/100 |
| Backtest evidence | 35/100 |
| Fundamentals trend | 50/100 |
| Score | 44/100 |
| Composite Score | 44/100 |
| Evidence Tier | backtested |

### Trade now: TSLA entry blocked by trend strength

\*\*Current state: wait.\*\* TSLA closed the latest session at $380.84. The first entry condition — price above $3.00 — is trivially met. The trend condition is not: price sits $19.75 below the 50-day simple moving average at $400.59, leaving it close but unmet.

The real blockers are ADX (14) and OBV. TSLA's ADX (14) sits at 14.4, and the strategy requires it above 25 to confirm a trending move, so it needs to climb roughly 11 points from here. That gap puts the condition status at "far," meaning no meaningful trend strength is present today. OBV is reporting as unknown, which means the volume-confirmation gate cannot be evaluated until a live feed supplies a value.

On the risk side, the strategy's fixed stop loss is 12% and the primary take-profit target is 20%, giving an effective reward-to-risk ratio of roughly 1.67:1 at the rule level. In price terms on TSLA, a hypothetical entry at $380.84 would place the stop near $335.14 and the first profit target near $457.01. "Wait" means do nothing until ADX pushes through 25 and OBV turns positive — both conditions must fire on a daily close before a long signal is valid.

The 60-month backtest produced 263 trades with a 42.6% win rate, a 6.9% return, and a 10.0% maximum drawdown. However, the 24-month window was negative at -7.5% with a 10.5% drawdown, and no parameter variant survived the final holdout — the recommendation is explicitly no-optimization. Treat the current ruleset as the fixed configuration to monitor, not something to tune.

#### DIA price and trigger map

Uses the idea timeframe and keeps price levels on the price axis.

| Measure | Value |
| --- | ---: |
| Ticker | DIA |
| Timeframe | 1d |

#### LLY price and trigger map

Uses the idea timeframe and keeps price levels on the price axis.

| Measure | Value |
| --- | ---: |
| Ticker | LLY |
| Timeframe | 1d |

#### TSLA price and trigger map

Uses the idea timeframe and keeps price levels on the price axis.

| Measure | Value |
| --- | ---: |
| Ticker | TSLA |
| Timeframe | 1d |

### The rotation case has real fundamental teeth

The idea's core claim — that old-economy and consumer-facing companies are carrying the market while AI chips struggle — finds genuine support in the underlying fundamentals. The CNBC coverage of the Dow rising over 400 points to a record while the Nasdaq fell, alongside the Yahoo Finance report on memory-chip supply glut fears hitting SanDisk (-11%), Seagate (-7%), and Micron (-4%), provides a real-time snapshot of this divergence. The Yahoo Finance piece on Tesla's Q2 deliveries beating estimates at 480,126 vehicles validates the demand narrative at the center of the thesis. Eli Lilly's fundamentals are the strongest pillar of the bull case. The company posted 44.7% year-over-year revenue growth, an 83.0% gross margin that places it in the 79th percentile of its Health Care peer group, and a return on equity of 77.8% — in the 91st percentile among 966 peers. That is not just a…

#### TSLA Debt to equity

Debt to equity trend from CommonQuant fundamentals/XBRL data; -4383.3% from first to latest point.

| Measure | Value |
| --- | ---: |
| 2010-12-31 | \0.34691472508790233 ratio |
| 2011-06-30 | \0.3850659488250892 ratio |
| 2011-09-30 | \0.7649990820011017 ratio |
| 2011-12-31 | \1.197683501082372 ratio |
| 2012-03-31 | \2.211699182447977 ratio |
| 2012-06-30 | \6.367515872378044 ratio |
| 2012-09-30 | \-14.85944394618834 ratio |
| Latest Value | \-14.85944394618834 ratio |
| Change Pct | \-4383.313123253332 ratio |
| Ticker | TSLA |
| Timeframe | reported periods |

#### TSLA Gross margin

Gross margin trend from CommonQuant fundamentals/XBRL data; +273.5% from first to latest point.

| Measure | Value |
| --- | ---: |
| 2009-12-31 | \0.08517727772169764% |
| 2010-03-31 | \0.18508552758024216% |
| 2010-06-30 | \0.2054777820671719% |
| 2010-06-30 | \0.22041894032740716% |
| 2010-09-30 | \0.2412438787939049% |
| 2010-09-30 | \0.2975576966166256% |
| 2010-12-31 | \0.26323408483519495% |
| 2011-03-31 | \0.36769324903120537% |
| 2011-06-30 | \0.3408177162526469% |
| 2011-06-30 | \0.31816540888071376% |
| Latest Value | \0.31816540888071376% |
| Change Pct | \273.53319733963025% |
| Ticker | TSLA |
| Timeframe | reported periods |

#### LLY sector percentile check

Ranks LLY against 966 companies in its sector using CommonQuant fundamentals.

| Measure | Value |
| --- | ---: |
| Return on equity | \90.6832298136646th percentile |
| Gross margin | \79.42477876106194th percentile |
| Revenue growth (YoY) | \60.84905660377359th percentile |
| Ticker | LLY |
| Sector | Health Care |
| Peer Count | 966 |

### Scores

- **Conviction score breakdown:** 44
- **Thesis support:** 58
- **Trade readiness:** 30
- **Risk quality:** 45
- **Backtest evidence:** 35
- **Fundamentals trend:** 50

### Watch items

- **TSLA — ADX (14)**
- **TSLA — Price vs 50-day SMA**
- **TSLA — OBV**
- **TSLA — RSI (14)**
- **DIA — Price vs 50-day SMA**
- **DIA — Price above 3**
- **DIA — ADX (14) above 25**
- **DIA — Price above SMA (50)**
- **LLY — Price above 3**
- **LLY — ADX (14) above 25**

## Key details

- Symbols: DIA, LLY, TSLA
- Timeframes: D1
- Tags: \#stock, \#rotation, \#growth

## Community

- Upvotes: 67
- Views: 1,395
- Copies: 0
- Cosigns: 0

## News sources

- [Dow rises more than 400 points to record, Nasdaq falls again as chipmakers struggle: Live updates](https://www.cnbc.com/2026/07/01/stock-market-today-live-updates.html) — CNBC
- [Eli Lilly Hits Highs on GLP-1 Medicare Inclusion, Huge Results](https://finance.yahoo.com/healthcare/articles/eli-lilly-hits-highs-glp-142311427.html) — Yahoo Finance
- [SanDisk Sinks 11%, Seagate Falls 7%, Micron Slides 4% on Memory Supply-Glut Fears](https://finance.yahoo.com/markets/stocks/articles/sandisk-sinks-11-seagate-falls-160250009.html) — Yahoo Finance
- [Tesla Q2 2026 deliveries beat estimates at 480,126 vehicles](https://finance.yahoo.com/markets/stocks/articles/tesla-q2-2026-deliveries-beat-131720998.html) — Yahoo Finance

## Discussion (1)

**@deep\_chart6** · 1 upvotes

For DIA, I would watch whether the 1d move can hold after 2026-07-03.

## Related

- [DIA trade ideas](https://commonquant.ai/markets/dia)
- [LLY trade ideas](https://commonquant.ai/markets/lly)
- [TSLA trade ideas](https://commonquant.ai/markets/tsla)
- [Latest market news](https://commonquant.ai/news)

## About CommonQuant Research

Ideas and Advanced Analysis are generated with fresh, LLM-selected news headlines and grounded in SEC XBRL fundamentals and peer percentiles. Strategies built from these ideas are automatically backtested (over a timeframe-dependent historical window with walk-forward tuning) and stress-tested before they can go live, then monitored against the news hourly while they run.